Weight Loss Intervention In Adults Research Articles

Weight Loss Interventions for Adults With Obesity-Related Asthma

Weight Loss Interventions for Adults With Obesity-Related Asthma

Economic Evaluations of Anti-obesity Interventions in Obese Adults: An Umbrella Review.

This umbrella review amalgamates the outcomes of economic evaluations pertaining to bariatric surgeries, pharmacotherapy, and gastric balloon for adult obesity treatment. Six databases were systematically searched. The inclusion criteria were established following the Patient/population Intervention Comparison and Outcomes (PICO) statement. Fifteen reviews met all the inclusion criteria. Eight studies focused on surgical interventions, four on pharmacotherapy, and three on both interventions. No systematic review of the economic evaluation of gastric balloons was identified. The majority of reviews advocated bariatric surgery as a cost-effective approach; however, there was discordance in the interpretation of pharmacological cost-effectiveness. Most of the economic evaluations were conducted from the payer and the healthcare system perspectives. We propose that future economic evaluations assessing weight loss interventions in adults adopt a societal perspective and longer-term time horizons.

Weight Loss Interventions for Adults With Obesity-Related Asthma

Obesity is a common asthma comorbidity in adults, contributing to higher patient morbidity and mortality. Conversely, weight loss can reduce the impact of obesity on asthma and improve patient outcomes by diverse mechanisms including modulating airway inflammation, reducing oxidative stress, and improving lung function. Multiple lifestyle, nonpharmacological, pharmacological, and surgical interventions are effective at reducing weight in the general population. Fewer have been studied specifically in the context of patients with asthma. However, increasingly effective pharmacologic options for weight loss highlight the need for allergists and pulmonologists to understand the range of approaches that may directly or indirectly yield clinical benefits in asthma management. Weight loss interventions often require multidisciplinary support to create strategies that can realistically achieve a patient's personalized asthma and weight goals. This includes minimizing the adverse weight effects of glucocorticoids, which remain a mainstay of asthma management. Disparities in access, cost, and insurance coverage of weight loss interventions remain acute challenges for providers and patients. Future studies are needed to elucidate mechanisms of action of specific weight loss interventions on short-term and long-term asthma outcomes.

Cognitive Behavioural Therapies for Weight-Loss in Adults: A Scoping Review Protocol.

Obesity and being overweight are very important public health issues due to their increasing prevalence worldwide. Third-wave cognitive behavioural therapies (3wCBT) have emerged in the last few years to promote weight loss. However, the scientific evidence identifying the most commonly used 3wCBT in weight-loss interventions in adults is still needed. The objective of this scoping review will be to identify the most widely researched 3wCBT used to facilitate weight loss in an adult population who are overweight and obese, according to the published scientific literature. The search will be carried out independently by two authors in PubMed (MEDLINE), Scopus, EMBASE, Web of Science, and PsycINFO, using search equations that contain keywords related to our search question: (1) population: adult and elderly population, (2) intervention: terms related to 3wCBT, and (3) results: weight loss or weight management. The data extraction will be performed following the indications of the Cochrane manual, and the results will be presented in three tables. The 3wCBTs have shown promising results for weight loss, but it is not yet known which of them is the most widely used to achieve weight loss in the adult population. Thus, the results of this scoping review could guide professionals in the psychological treatment of obesity and being overweight.

Changes In Physical Activity Across A 6 Month Weight Loss Intervention In Adults With Intellectual Disabilities

Changes In Physical Activity Across A 6 Month Weight Loss Intervention In Adults With Intellectual Disabilities

Body composition changes and their relationship with obstructive sleep apnoea symptoms, severity: The Sleeping Well Trial

Obstructive sleep apnoea (OSA) and obesity share a complex bi-directional relationship as location of body fat and changes in regional body composition may be more important for OSA improvement than changes in total body weight only. The aim of this study was to evaluate the impact of a 6-month weight loss intervention for adults newly diagnosed with moderate-severe OSA and obesity on regional body composition. The secondary aims evaluated the relationship between changes in OSA symptoms and severity and anthropometry and regional body composition during the first 12-months after commencing CPAP and explored differences in outcomes between males and females. Participants (n=59) received CPAP overnight at home alongside a 6-month modified fasting intervention with 12-months follow up. Regional body composition was measured by Dual X-ray absorptiometry, (DXA) and anthropometry before and after the lifestyle intervention. OSA severity was measured using the apnoea hypopnea index via overnight polysomnography and OSA symptoms were measured using the Epworth Sleepiness scale. Forty-seven adults (74% male) had complete measures available with a mean age of 50.0y (SD 11.0) and BMI 34.1kg/m2 (SD 5.0). Following the intervention average fat mass changed by-5.27kg (5.36), p<0.001) and visceral adipose tissue (-0.63kg (0.67), p<0.001) significantly decreased in males only with a maintenance of fat-free mass (mean-0.41kg (1.80), p=0.18). Females (n=12) had significant decreases in waist circumference (mean-3.36cm (3.18) p<0.01), android lean (-0.12kg (0.04), p<0.05) and android total mass (-0.28kg (0.39), p<0.05) only. Regional body composition changes in males were positively associated with improvements in OSA severity (p<0.01) but not OSA symptoms. Improvements in regional body composition were seen in males only which were related to improvements in OSA severity but not OSA symptoms. Females may exhibit different OSA pathophysiology and may require different treatment approaches. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=369975&isReview=trueAACTRN12616000203459 ACTRN12616000203459.

EHealth weight loss interventions for adults with low income: A systematic review.

There is a tremendous opportunity for electronic health services (eHealth) to reach adults with low income who want to participate in weight loss interventions, but face barriers in access. This review (a) synthesizes and presents results from all studies evaluating the effectiveness of eHealth weight loss interventions for adults with low income and (b) describes the strategies used to tailor them to these groups. Electronic databases were searched for studies examining the effectiveness of eHealth weight loss interventions designed for adults with low income and screened for eligibility by two independent reviewers. All experimental study designs were included. Data were extracted, results were qualitatively synthesized, and studies were assessed for quality. Nine studies met the inclusion criteria (N = 1,606 total participants). Four studies reported significant reductions in weight of small to moderate magnitude among participants in eHealth interventions (M weight loss = -2.2 kg; SD = 1.6). Many studies did not describe how they tailored the intervention for adults with low income; however, studies that achieved significant results tended to use more tailoring strategies. Most studies reported high retention rates. Three studies were rated as strong quality, four as moderate, and two as weak. Evidence is limited that eHealth weight loss interventions for this population are effective in achieving clinically and statistically significant weight reductions. While interventions that used more tailoring strategies tended to be more effective, studies that use the rigorous methodology and describe interventions in more depth could better elucidate whether eHealth interventions are an effective approach in this population. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Supplemental Material for eHealth Weight Loss Interventions for Adults With Low Income: A Systematic Review

Supplemental Material for eHealth Weight Loss Interventions for Adults With Low Income: A Systematic Review

A 12-month weight loss intervention in adults with obstructive sleep apnoea: is timing important? A step wedge randomised trial

Background/ObjectivesContinuous positive airway pressure (CPAP) concomitant with weight loss is a recommended treatment approach for adults with moderate-severe obstructive sleep apnoea (OSA) and obesity. This requires multiple synchronous behaviour changes. The aim of this study was to examine the effectiveness of a 6-month lifestyle intervention and to determine whether the timing of starting a weight loss attempt affects weight change and trajectory after 12 months in adults newly diagnosed with moderate-severe OSA and treated at home with overnight CPAP.MethodsUsing a stepped-wedge design, participants were randomised to commence a six-month lifestyle intervention between one and six-months post-enrolment, with a 12-month overall follow-up. Adults (n = 60, 75% males, mean age 49.4 SD 10.74 years) newly diagnosed with moderate-severe OSA and above a healthy weight (mean BMI 34.1 SD 4.8) were recruited.ResultsAfter 12 months, exposure to the intervention (CPAP and lifestyle) resulted in a 3.7 (95% CI: 2.6 to 4.8, p < 0.001) kg loss of weight compared to the control condition (CPAP alone). Timing of the weight loss attempt made no difference to outcomes at 12 months. When exposed to CPAP only (control period) there was no change in body weight (Coef, [95% CI] 0.03, [−0.3 to 0.36], p = 0.86).ConclusionsThe lifestyle intervention resulted in a modest reduction in body weight, while timing of commencement did not impact the degree of weight loss at 12 months. These findings support the recommendation of adjunctive weight-loss interventions within six-months of starting CPAP.

Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss

BackgroundAccruing evidence indicates that accumulation of advanced glycation end products (AGEs) and activation of the receptor for AGEs (RAGE) play a significant role in obesity and type 2 diabetes. The concentrations of circulating RAGE isoforms, such as soluble RAGE (sRAGE), cleaved RAGE (cRAGE), and endogenous secretory RAGE (esRAGE), collectively sRAGE isoforms, may be implicit in weight loss and energy compensation resulting from caloric restriction. ObjectivesWe aimed to evaluate whether baseline concentrations of sRAGE isoforms predicted changes (∆) in body composition [fat mass (FM), fat-free mass (FFM)], resting energy expenditure (REE), and adaptive thermogenesis (AT) during weight loss. MethodsData were collected during a behavioral weight loss intervention in adults with obesity. At baseline and 3 mo, participants were assessed for body composition (bioelectrical impedance analysis) and REE (indirect calorimetry), and plasma was assayed for concentrations of sRAGE isoforms (sRAGE, esRAGE, cRAGE). AT was calculated using various mathematical models that included measured and predicted REE. A linear regression model that adjusted for age, sex, glycated hemoglobin (HbA1c), and randomization arm was used to test the associations between sRAGE isoforms and metabolic outcomes. ResultsParticipants (n = 41; 70% female; mean ± SD age: 57 ± 11 y; BMI: 38.7 ± 3.4 kg/m2) experienced modest and variable weight loss over 3 mo. Although baseline sRAGE isoforms did not predict changes in ∆FM or ∆FFM, all baseline sRAGE isoforms were positively associated with ∆REE at 3 mo. Baseline esRAGE was positively associated with AT in some, but not all, AT models. The association between sRAGE isoforms and energy expenditure was independent of HbA1c, suggesting that the relation was unrelated to glycemia. ConclusionsThis study demonstrates a novel link between RAGE and energy expenditure in human participants undergoing weight loss.This trial was registered at clinicaltrials.gov as NCT03336411.

Body composition changes at 12 months following different surgical weight loss interventions in adults with obesity: A systematic review and meta‐analysis of randomized control trials

SummaryTo determine relative lean mass and fat mass changes in adults with obesity following surgical weight loss interventions, a systematic review and meta‐analysis was conducted. The Cochrane Central Register of Controlled Trials, PubMed, Web of Science, EMBASE, and Scopus were screened for eligible studies. Inclusion criteria included randomized controlled trials (RCTs) performed in populations with obesity (body mass index ≥30 kg/m2) aged over 18 years, who underwent any type of bariatric surgery and reported body composition measures via dual‐energy X‐ray absorptiometry or bio‐electrical impedance analysis. Authors conducted full text screening and determined that there were six RCTs eligible for inclusion, with data extracted at 12 months post‐surgery. Meta‐analysis revealed that, relative to gastric banding, Roux‐en‐Y gastric bypass (RYGB) led to greater total body mass loss (mean difference [MD]: −9.33 kg [95% CI: −12.10, −6.56]) and greater fat mass loss (MD: −8.86 kg [95% CI: −11.80, −5.93], but similar lean mass loss (MD: −0.55 kg [95% CI: −3.82, 2.71]. RYGB also led to similar changes in total body mass, fat mass, and lean mass compared with sleeve gastrectomy. RYGB results in greater 12‐month weight and fat loss, but similar changes in lean mass, compared with gastric banding. Further RCTs comparing body composition changes following different bariatric surgery procedures are required.

Abstract 007: The Impact Of A Personalized Weight Loss Diet On Dietary Measures In Adults With Prediabetes And Early-stage Type 2 Diabetes

Introduction: There is limited research examining dietary changes in adults with prediabetes who are following a diet personalized to predict postprandial glycemic response (PPGR). Objective: We compared dietary changes in subjects randomized to a low-fat, one-size-fits-all diet ( Standardized ) or to a diet personalized to minimize PPGR ( Personalized ). Methods: Dietary data collected to-date were analyzed from the Personal Diet study, a clinical trial to compare two behavioral weight loss interventions in adults with prediabetes or early-stage type 2 diabetes. All subjects had resting energy expenditure (REE) measured at baseline using indirect calorimetry. Both arms were instructed to restrict energy intake (-500 kcal/day, based on REE and a physical activity factor of 1.4), log daily dietary intake with a smartphone app, and attend scheduled behavioral counseling sessions. The Standardized arm received app feedback about energy and fat intake, while the Personalized arm received app feedback about energy intake and meal specific predicted PPGR determined from a gut microbiome-based machine learning algorithm. At baseline, 3 months, and 6 months, subjects completed one 24-hour dietary recall using the Automated Self-Administered 24-hour Dietary Assessment Tool. Total energy, total carbohydrate, total sugars, fiber, total fat, saturated fat, monounsaturated fat, polyunsaturated fat, and protein were measured using the USDA Food and Nutrient Database for Dietary Studies 2011-2012. Macronutrient intakes were analyzed as percentage of energy (%E). Linear mixed modelling, with random intercepts and slopes and an unstructured covariance pattern, was used to analyze dietary changes within- and between-arms from baseline to 3 and 6 months. Fixed effects were included for study arm, time period, and interaction of study arm and time period. A random effect was included for subjects. Models were adjusted for age and sex. Results: Dietary assessments were completed at baseline (n=66 Personalized ; n=65 Standardized ), 3 months (n=50 Personalized ; n=36 Standardized ), and 6 months (n=47 Personalized ; n=39 Standardized ). The Personalized arm had a greater reduction than the Standardized arm in energy (β: -342 kcal; 95% CI: -672, -12) and %E from carbohydrate (β: -6.2; 95% CI: -11.7, -0.6) and sugars (β: -4.9; 95% CI: -8.8, -1.0) from baseline to 3 months, but there were no between-arm differences in dietary measures at 6 months. Within-arm, Personalized had decreases in energy (β: -327 kcal; 95% CI: -546, -108) and %E from carbohydrate (β: -4.6; 95% CI: -8.2, -0.9) from baseline to 3 months. In the Standardized arm, %E from sugars increased from baseline to 3 months (β: 3.0; 95% CI: 0.02, 5.9). Conclusions: Personalized had greater reductions than Standardized in energy and %E from carbohydrate and sugars over the first 3 months of the intervention, but dietary changes were similar by 6 months.

Determining Predictors of Weight Loss in a Behavioral Intervention: A Case Study in the Use of Lasso Regression.

ObjectiveThis study investigates predictors of weight loss among individuals with serious mental illness participating in an 18-month behavioral weight loss intervention, using Lasso regression to select the most powerful predictors.MethodsData were analyzed from the intervention group of the ACHIEVE trial, an 18-month behavioral weight loss intervention in adults with serious mental illness. Lasso regression was employed to identify predictors of at least five-pound weight loss across the intervention time span. Once predictors were identified, classification trees were created to show examples of how to classify participants into having likely outcomes based on characteristics at baseline and during the intervention.ResultsThe analyzed sample contained 137 participants. Seventy-one (51.8%) individuals had a net weight loss of at least five pounds from baseline to 18 months. The Lasso regression selected weight loss from baseline to 6 months as a primary predictor of at least five pound 18-month weight loss, with a standardized coefficient of 0.51 (95% CI: −0.37, 1.40). Three other variables were also selected in the regression but added minimal predictive ability.ConclusionsThe analyses in this paper demonstrate the importance of tracking weight loss incrementally during an intervention as an indicator for overall weight loss, as well as the challenges in predicting long-term weight loss with other variables commonly available in clinical trials. The methods used in this paper also exemplify how to effectively analyze a clinical trial dataset containing many variables and identify factors related to desired outcomes.

An Earlier First Meal Timing Associates with Weight Loss Effectiveness in A 12-Week Weight Loss Support Program.

Recent studies have reported that meal timing may play an important role in weight regulation, however it is unknown whether the timing of meals is related to the amount of weight loss. This study aimed to examine the relationship between indices of meal timing and weight loss during weight loss intervention in adults. A 12-week weight loss support program was conducted for 97 adults (age: 47.6 ± 8.3 years, BMI: 25.4 ± 3.7 kg/m2). After the program, body weight decreased by −3.0 ± 2.7%. Only the start of the eating window was positively correlated with the weight change rate in both sexes (men: r = 0.321, p = 0.022; women: r = 0.360, p = 0.014). The participants were divided into two groups based on the start of the eating window as follows: the early group (6:48 ± 0:21 AM) and the late group (8:11 ± 1:05 AM). The weight loss rate in the early group was significantly higher (−3.8 ± 2.7%) than that in the late group (−2.2 ± 2.5%). The present results showed that the start of the early eating window was associated with weight loss and suggested paying attention to meal timing when doing weight loss.

Modifying Diet and Exercise in MS (MoDEMS): Study design and protocol for a telehealth weight loss intervention for adults with obesity & Multiple Sclerosis

Weight loss improves overall health, and reduces inflammation, risk of stroke, heart attack, diabetes, certain cancers, and death among individuals with obesity. Weight loss also improves mobility, increases stamina, and elevates mood. Between 25 and 33% of people with Multiple Sclerosis (pwMS) have obesity. Multiple Sclerosis (MS) and obesity are independently associated with reduced mobility, increased fatigue, and depression. Most behavioral weight loss trials exclude individuals with neurologic disease. Consequently, few studies have examined the effects of weight loss on symptom presentation and health outcomes among pwMS and obesity.This is the first study examining the efficacy of a comprehensive behavioral weight loss intervention designed specifically for pwMS. The purpose of this study is to develop and assess the efficacy of a telehealth administered weight loss intervention tailored for pwMS. Additionally, we aim to determine if weight loss reduces physical and emotional symptoms in individuals with obesity and MS. We will enroll 70 pwMS in a wait-list crossover trial to examine the efficacy of our intervention. If successful, findings will help determine whether we can help participants lose clinically significant weight – and whether weight loss among pwMS and overweight/obesity reduces fatigue, and improves mobility, mood, and quality of life.

Behavioural mediators of reduced energy intake in a physical activity, diet, and sleep behaviour weight loss intervention in adults

Reduced energy intake is a major driver of weight loss and evidence suggests that physical activity, dietary, and sleep behaviours interact to influence energy intake. Energy restriction can be challenging to sustain. Therefore to improve intervention efficacy, evaluation of how changes in physical activity, diet, and sleep behaviours mediate reduced energy intake in adults with overweight/obesity who participated in a six-month multiple-behaviour-change weight loss intervention was undertaken. This was a secondary analysis of a 3-arm randomised controlled trial. Adults with body mass index (BMI) 25–40 kg/m2 were randomised to either: a physical activity and diet intervention; physical activity, diet, and sleep intervention; or wait-list control. Physical activity, dietary intake, and sleep was measured at baseline and six-months using validated measures. The two intervention groups were pooled and compared to the control. Structural equation modelling was used to estimate the mediated effects (AB Coefficient) of the intervention on total energy intake. One hundred and sixteen adults (70% female, 44.5y, BMI 31.7 kg/m2) were enrolled and 70% (n = 81) completed the six-month assessment. The significant intervention effect on energy intake at six-months (−1011 kJ/day, 95% CI -1922, −101) was partially mediated by reduced fat intake (AB = −761.12, 95% CI -1564.25, −53.74) and reduced consumption of energy-dense, nutrient-poor foods (AB = −576.19, 95% CI -1189.23, −97.26). In this study, reducing fat intake and consumption of energy-dense, nutrient-poor foods was an effective strategy for reducing daily energy intake in adults with overweight/obesity at six-months. These strategies should be explicitly targeted in future weight loss interventions.

What are the effects of long-term non-pharmacological weight loss interventions for adults with prediabetes?

What are the effects of long-term non-pharmacological weight loss interventions for adults with prediabetes?

An app-, web- and social support-based weight loss intervention for adults with obesity: the \u2018HelpMeDoIt!\u2019 feasibility randomised controlled trial

BackgroundSocial support has an important role in successful weight loss. The aim of this study was to assess the feasibility and acceptability of an app-, web- and social support-based intervention in supporting adults with obesity to achieve weight loss.MethodsThe intervention and evaluation methods were tested in a feasibility randomised controlled trial. Adults in the Greater Glasgow and Clyde Health Board area of Scotland with a body mass index ≥ 30 kg/m2 were recruited and randomised 2:1 (intervention to control). The feasibility and acceptability of the intervention and trial methods were assessed against pre-specified progression criteria, via process, economic and outcome evaluation. Three primary outcomes were explored: BMI, diet and physical activity, as well as a number of secondary outcomes. The intervention group had access to the HelpMeDoIt! intervention for 12 months. This encouraged them to (i) set goals, (ii) monitor progress and (iii) harness social support by inviting ‘helpers’ from their existing social network. The control group received a healthy lifestyle leaflet.ResultsOne hundred and nine participants were recruited, with 84 participants (77%) followed-up at 12 months. The intervention and trial methods were feasible and acceptable. Participants and helpers were generally positive. Of the 54 (74%) participants who downloaded the app, 48 (89%) used it. Interview data indicated that HelpMeDoIt! promoted social support from existing social networks to support weight loss. This support was often given outside of the app.Outcomes were compared using linear regression models, with randomised group, the baseline measurement of the outcome, age and gender as predictor variables. These analyses were exploratory and underpowered to detect effects. However, all pre-specified primary outcome effects (BMI, diet and physical activity) had wide confidence intervals and were therefore consistent with clinically relevant benefits. Objective physical activity measures perhaps showed most potential (daily step count (p = 0.098; 1187 steps [− 180, 2555])) and sedentary time (p = 0.022; − 60.8 min [− 110.5, − 11.0]). However, these outcomes were poorly completed.ConclusionsThe study demonstrated that a novel social support intervention involving support from participants’ close social networks, delivered via app and website, has potential to promote weight loss and is feasible and acceptable.Trial registrationISRCTN, ISRCTN85615983. Registered 25 September 2014

Circulating Klotho Response To A Behavioral Weight Loss Intervention In Adults With Overweight Or Obesity

Klotho, a biomarker of aging, is associated with a slower aging process. Klotho concentration is lower among adults with obesity compared to normal-weight adults, and exercise may independently increase levels of Klotho. Whether Klotho is altered by weight loss and whether there is an added effect of exercise are not understood. PURPOSE: This study examined changes in Klotho concentration in response to a behavioral weight loss intervention among adults with overweight or obesity. METHODS: A subset of 152 adults (age: 45.4+8.0 years; BMI: 32.1+3.7 kg/m2) who participated in a 12-month weight loss intervention were classified as an intervention “responder” (achieved >10% weight loss at both 6- and 12 months) or “non-responder” (achieved <5% weight loss at both 6- and 12 months). Intervention conditions included: 1) diet only (1200-1800 kcal/day), 2) diet plus 150 min/wk of moderate-to-vigorous intensity physical activity (MVPA) per week, 3) or diet plus 250 min/wk of unsupervised MVPA per week. Measures of height, weight, body composition, cardiorespiratory fitness, and Klotho were completed at baseline, 6-, and 12 months. Klotho was analyzed using solid-phase sandwich ELISA kits. RESULTS: There were significant (p<0.0001) changes in weight (-12.5±9.1 kg), percent body fat (-7.1±5.5%), lean body mass (-1.7±2.0 kg), and cardiorespiratory fitness (+3.3±4.1 ml/kg/min) from baseline to 12-months. Klotho significantly (p=0.009) changed across the 12 months (baseline: 933±381 pg/mL; 6 months: 985±450 pg/mL; 12 months: 940±423 pg/mL), with no difference by intervention group or weight loss response. Participants who performed physical activity had non-significantly greater changes in Klotho. Klotho was consistently associated with lean body mass at baseline (r=-0.19), 6 (r=-0.23), and 12 months (r=-0.19) (p<0.05). Klotho was not predictive of change in weight, body composition, or fitness. CONCLUSION: Klotho significantly, but modestly, increases with weight loss; however, the increase in Klotho was not sustained throughout the intervention. There may be an influence of physical activity on change in Klotho with weight loss, but this warrants further investigation. Further investigation to examine how weight loss and physical activity may alter biomarkers of aging in adults with obesity may be warranted.

Do weight loss interventions in adults with obesity reduce the risk of major adverse cardiac events?

Lu, Jessica MD; Smith, Rachel MD; Yang, Ping MD; Raetz, Jaqueline MD Author Information